AFLAC Incorporated – Consensus Indicates Potential -5.8% Downside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

AFLAC Incorporated found using ticker (AFL) now have 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The target price ranges between 80 and 54 with the average target price sitting at 67.77. Now with the previous closing price of 71.91 this now indicates there is a potential downside of -5.8%. There is a 50 day moving average of 64.28 and the 200 day MA is 60.81. The market cap for the company is $44,980m. Find out more information at: https://www.aflac.com

The potential market cap would be $42,391m based on the market concensus.

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search